Ligand · G7L
G7L · N-methyl-N-[[4-(trifluoromethyl)-1,3-thiazol-2-yl]methyl]prop-2-enamide
G7L, N-methyl-N-[[4-(trifluoromethyl)-1,3-thiazol-2-yl]methyl]prop-2-enamide (C9 H9 F3 N2 O S, 250.2 g/mol), in the MolNFT structures on GenesisL1: bound in 4 records (2 PDB entries). Every binding site with its residues within 4.5 Å, the…
- Component
- G7L
- Formula
- C9 H9 F3 N2 O S
- Class
- ligand
- Structures
- 4
- PDB entries
- 2
Binding sites
G7L in 4 structures; the first of them:
- 7WYL · Structure of the EV71 3Cpro with 337 inhibitor · G7L A201 · binds ILE104, HIS108, MET109, MET112, VAL114, PHE140, THR142, ALA144 and 3 more
- 7WYM · Structure of the SARS-COV-2 main protease with 337 inhibitor · G7L A401 · binds HIS41, MET49, TYR54, ASN142, GLY143, SER144, CYS145, HIS163 and 5 more
- 7WYL · Structure of the EV71 3CPRO with 337 inhibitor · G7L A201 · binds ILE104, MET109, VAL114, PHE140, THR142, ALA144, GLY145, GLN146 and 1 more
- 7WYM · Structure of the SARS-cov-2 main protease with 337 inhibitor · G7L A401 · binds HIS41, MET49, TYR54, ASN142, GLY143, CYS145, HIS164, MET165 and 3 more
Residues it binds most
MET 4, HIS 3, CYS 4, GLN 4, GLY 4, ALA 2, ARG 2, ASN 2, ASP 2, ILE 2 (residue and the binding sites it lines).
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.